Dihexa
Also known as N-hexanoic-Tyr-Ile-(6) aminohexanoic amide
A potent cognitive-enhancing peptide derived from angiotensin IV. Reported to be 10 million times more potent than BDNF at promoting synaptogenesis.
Regulatory Pathway
Dosing Protocol
Typical Dose
5-20 mg oral or sublingual daily
Frequency
Once daily
Duration
Cycles of 2-4 weeks
Timing & Administration
Administer via Oral, sublingual, or intranasal. Frequency: Once daily.
Popular Uses
Mechanism of Action
Activates hepatocyte growth factor signaling via the c-Met receptor, promoting dendritic spine formation, enhancing synaptic connections, and supporting neuronal survival. Crosses the blood-brain barrier.
Research Summary
Evidence level: animal studies. Clinical status: Preclinical - Research compound.
Side Effects & Safety
Important Warnings
- Activates c-Met pathway which may promote cancer cell growth - avoid if history of cancer
- No human clinical trials conducted.
References
No references available.
Related Peptides
Browse all →A synthetic peptide derived from tuftsin, an immunomodulatory peptide. Approved in Russia for anxiety and nootropic effects.
View profileSynthetic peptide derived from ACTH (4-10) fragment with added Pro-Gly-Pro sequence. Used clinically in Russia for stroke, traumatic brain injury, and cognitive disorders.
View profileA neuropeptide mixture derived from porcine brain tissue, indicated for neurological conditions including stroke recovery, cognitive decline, and traumatic brain injury.
View profile